BREAST CANCER NOW CATALYST PROGRAM program explores aspirin as part of potential therapy against the aggressive form of breast cancer. Experts hope that cheap and affordable medicine can safely work in a complex with immunotherapy, News Medical writes.
In an innovative study, it is studied whether the reception of aspirin is commonly used as an anesthetic, together with the Abelumab preparation for immunotherapy, increase its efficiency for people suffering from breast cancer. When used in combination, drugs can potentially prevent the death of people from this disease.
In the framework of the program, Pfizer provided a grant funding program for independent medical research and access to several drugs.
“Try to use such a drug like aspirin, I wonder because it is widely available and cheap in production. We hope that our test will show that in combination with immunotherapy aspirin can strengthen its action and, ultimately, provide new A safe method of treating breast cancer, “said oncologist from the Christie Foundation National Health Service, Dr. Ann Armstrong.
Researchers note that three times negative breast cancer is difficult to amenable to therapy, the treatment options for this type are usually limited to a combination of surgical intervention, chemotherapy and radiation therapy, and may also have exhausting side effects.
Previously, scientists from Columbia University called signs of one of the most aggressive types of cancer. The yellowness of the skin and proteins of the eyes can talk about the damage to the pancreas, they can diagnose the disease at an early stage. According to the conclusions of scientists, the pancreas tumor can grow years, and the patient will not suspect it because of a special location.